Passage BIO, Inc.
PASG- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001787297
In the last 90 days, Passage BIO, Inc. insiders filed 1 open-market purchase and 0 sales; 29 institutions reported holding it in 13F filings for Q2 2026, worth $6.82M in total; no superinvestor holds it.
13F holders, Q3 2025
Institutional positions in Passage BIO, Inc. as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 32
- −9 vs. Q2 2025
- Shares held
- 1.65M
- −33.4M (−95.3%) vs. Q2 2025
- Total value
- $13.2M
- −$19.8M (−59.9%) vs. Q2 2025
- New holders
- 6
- 1 more added
- Sold out
- 15
- 25 more reduced
Compare with Q2 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PASG on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 29 | $6.82M |
| Q1 2026 | 35 | $13.8M |
| Q4 2025 | 30 | $18.6M |
| Q3 2025 | 32 | $13.2M |
| Q2 2025 | 41 | $33.0M |
| Q1 2025 | 42 | $12.8M |
| Q4 2024 | 46 | $21.6M |
| Q3 2024 | 45 | $27.1M |
| Q2 2024 | 45 | $32.0M |
| Q1 2024 | 51 | $54.4M |
| Q4 2023 | 52 | $33.1M |
| Q3 2023 | 51 | $21.3M |
| Q2 2023 | 56 | $31.4M |
| Q1 2023 | 59 | $34.1M |
| Q4 2022 | 68 | $51.6M |
| Q3 2022 | 76 | $49.3M |
| Q2 2022 | 87 | $99.6M |
| Q1 2022 | 110 | $133.2M |
| Q4 2021 | 102 | $277.7M |
| Q3 2021 | 103 | $419.1M |
| Q2 2021 | 102 | $558.8M |
| Q1 2021 | 90 | $786.5M |
Institutions, Q3 2025
Shares, value and share of portfolio for each institution holding Passage BIO, Inc.; share changes are against Q2 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Lynx1 Capital Management LP | 623,704 | $5.01M | 1.02% | −8,633,249−93.3% | Reduced |
| Vestal Point Capital, LP | 305,000 | $2.45M | 0.11% | −5,795,000−95.0% | Reduced |
| Erste Asset Management GmbH | 122,790 | $999.5K | 0.01% | −2,333,010−95.0% | Reduced |
| Vanguard Group Inc | 117,030 | $937.4K | 0.00% | −1,923,534−94.3% | Reduced |
| Renaissance Technologies LLC | 100,789 | $809.3K | 0.00% | −1,315,610−92.9% | Reduced |
| New Leaf Venture Partners, L.L.C. | 87,426 | $702.0K | 1.63% | −2,410,496−96.5% | Reduced |
| Tang Capital Management LLC | 75,000 | $602.3K | 0.02% | −1,425,000−95.0% | Reduced |
| OrbiMed Advisors LLC | 59,046 | $474.1K | 0.01% | −5,996,254−99.0% | Reduced |
| BlackRock, Inc. | 29,749 | $238.9K | 0.00% | −565,120−95.0% | Reduced |
| Geode Capital Management, LLC | 27,283 | $218.6K | 0.00% | −511,295−94.9% | Reduced |
| Acadian Asset Management LLC | 25,568 | $204.0K | 0.00% | −908,196−97.3% | Reduced |
| Squarepoint Ops LLC | 23,500 | $188.2K | 0.00% | +23,500 | New |
| Bridgeway Capital Management, LLC | 20,803 | $166.6K | 0.00% | −395,239−95.0% | Reduced |
| Citadel Advisors LLC | 19,091 | $152.9K | 0.00% | −228,591−92.3% | Reduced |
| Fiduciary Trust Co | 10,750 | $86.3K | 0.00% | −204,250−95.0% | Reduced |
| Morgan Stanley | 338 | $2.71K | 0.00% | −6,191−94.8% | Reduced |
| Tower Research Capital LLC (TRC) | 289 | $2.32K | 0.00% | −28,990−99.0% | Reduced |
| Barclays PLC | 212 | $1.70K | 0.00% | −4,012−95.0% | Reduced |
| MAI Capital Management | 200 | $1.61K | 0.00% | +200 | New |
| SBI Securities Co., Ltd. | 142 | $1.14K | 0.00% | −2,754−95.1% | Reduced |
| Citigroup Inc | 77 | $617 | 0.00% | +77 | New |
| Bank of America Corp | 28 | $225 | 0.00% | −475−94.4% | Reduced |
| Advisor Group Holdings, Inc. | 20 | $141 | 0.00% | −1,980−99.0% | Reduced |
| UBS Group AG | 17 | $137 | 0.00% | +14+466.7% | Added |
| Parallel Advisors, LLC | 16 | $128 | 0.00% | +16 | New |
| JPMorgan Chase & Co | 15 | $120 | 0.00% | −258−94.5% | Reduced |
| BNP Paribas Arbitrage, SA | 12 | $96 | 0.00% | −213−94.7% | Reduced |
| LRI Investments, LLC | 12 | $96 | 0.00% | −213−94.7% | Reduced |
| Harbour Investments, Inc. | 3 | $24 | 0.00% | +3 | New |
| Northwestern Mutual Wealth Management Co | 2 | $16 | 0.00% | +2 | New |
| CWM, LLC | 2 | $0 | 0.00% | −3−60.0% | Reduced |
| TSFG, LLC | 5 | $0 | 0.00% | −95−95.0% | Reduced |
| State Street Corp | 0 | $0 | 0.00% | −156,773−100.0% | Sold out |
| RBF Capital, LLC | 0 | $0 | 0.00% | −142,807−100.0% | Sold out |
| Northern Trust Corp | 0 | $0 | 0.00% | −112,056−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −82,983−100.0% | Sold out |
| DLK Investment Management, LLC | 0 | $0 | 0.00% | −61,000−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −60,889−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −47,156−100.0% | Sold out |
| Ritholtz Wealth Management | 0 | $0 | 0.00% | −25,392−100.0% | Sold out |
| Mariner, LLC | 0 | $0 | 0.00% | −11,934−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −11,724−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −11,591−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −10,733−100.0% | Sold out |
| Raymond James Financial Inc | 0 | $0 | 0.00% | −6,391−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −47−100.0% | Sold out |
| Mid-American Wealth Advisory Group, Inc. | 0 | $0 | 0.00% | −32−100.0% | Sold out |